Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events

Oncogene. 2008 Jul 17;27(31):4261-8. doi: 10.1038/onc.2008.74. Epub 2008 Mar 31.


Cyclin A/cdk2 has a role in progression through S phase, and a large pool is also activated in G2 phase. Here we report that this G2 phase pool regulates the timing of progression into mitosis. Knock down of cyclin A by siRNA or addition of a specific cdk2 small molecule inhibitor delayed entry into mitosis by delaying cells in G2 phase. The G2 phase-delayed cells contained elevated levels of inactive cyclin B/cdk1. However, increased microtubule nucleation at the centrosomes was observed, and the centrosomes stained for markers of cyclin B/cdk1 activity. Both microtubule nucleation at the centrosomes and the phosphoprotein markers were lost with short-term treatment of the cdk1/2 inhibitor roscovitine but not the Mek1/2 inhibitor U0126. Cyclin A/cdk2 localized at the centrosomes in late G2 phase after separation of the centrosomes but before the start of prophase. Thus G2 phase cyclin A/cdk2 controls the timing of entry into mitosis by controlling the subsequent activation of cyclin B/cdk1, but also has an unexpected role in coordinating the activation of cyclin B/cdk1 at the centrosome and in the nucleus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Butadienes / pharmacology
  • Cell Line
  • Cell Nucleus / physiology*
  • Centrosome / physiology*
  • Cyclin A / physiology*
  • Cyclin-Dependent Kinase 2 / metabolism*
  • Enzyme Inhibitors / pharmacology
  • G1 Phase
  • HeLa Cells
  • Humans
  • MAP Kinase Kinase 1 / metabolism
  • MAP Kinase Kinase 2 / metabolism
  • Mitosis*
  • Nitriles / pharmacology
  • Purines / pharmacology
  • RNA, Small Interfering
  • Roscovitine


  • Butadienes
  • Cyclin A
  • Enzyme Inhibitors
  • Nitriles
  • Purines
  • RNA, Small Interfering
  • U 0126
  • Roscovitine
  • MAP2K2 protein, human
  • CDK2 protein, human
  • Cyclin-Dependent Kinase 2
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2